BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 30153480)

  • 1. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.
    Das M; Law S
    Int J Biochem Cell Biol; 2018 Oct; 103():115-124. PubMed ID: 30153480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stem Cells and Targeting Strategies.
    Barbato L; Bocchetti M; Di Biase A; Regad T
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer stem cells as a possible source of tumor initiation and progression].
    Puchinskaya MV
    Vopr Onkol; 2016; 62(1):14-23. PubMed ID: 30444327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
    Alonso S; Jones RJ; Ghiaur G
    Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
    Ahmed N; Abubaker K; Findlay JK
    Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Cancer Stem Cells Microenvironment.
    Naik PP; Panda PK; Bhutia SK
    Adv Exp Med Biol; 2017; 1041():207-233. PubMed ID: 29204835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells and chemoresistance: The smartest survives the raid.
    Zhao J
    Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment promotes breast cancer chemoresistance.
    Mehraj U; Dar AH; Wani NA; Mir MA
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):147-158. PubMed ID: 33420940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
    Madden EC; Gorman AM; Logue SE; Samali A
    Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.
    Ingavle G; Das M
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4673-4696. PubMed ID: 36194142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
    Siddique HR; Saleem M
    Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.
    Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y
    Oncotarget; 2016 Aug; 7(34):55771-55788. PubMed ID: 27304054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia Stem Cells Microenvironment.
    Tabe Y; Konopleva M
    Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.